CompoAtlas

Waisence Q23 Qing Re Capsule

Waisence Q23 Qing Re Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lonicera japonicaLonicera japonica[37.5 mg,450 mg]Not identified
Forsythia suspensaForsythia suspensa[37.5 mg,450 mg]Not identified
Platycodon grandiflorumPlatycodon grandiflorum[28.2 mg,450 mg]Not identified
Inula japonicaInula japonica[28.2 mg,450 mg]Not identified
Achyranthes bidentataAchyranthes bidentata[28.2 mg,450 mg]Not identified
Rheum palmatumRheum palmatum[25 mg,450 mg]Not identified
Chrysanthemum indicumChrysanthemum indicum[25 mg,450 mg]Not identified
Angelica dahuricaAngelica dahurica[23.4 mg,450 mg]Not identified
Schizonepeta tenuifoliaSchizonepeta tenuifolia[18.7 mg,450 mg]Not identified
Ligusticum chuanxiongLigusticum chuanxiong[18.7 mg,450 mg]Not identified
Gardenia jasminoidesGardenia jasminoides[18.7 mg,450 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[18.7 mg,450 mg]Not identified
Gypsum fibrosumGypsum fibrosum[18.7 mg,450 mg]Not identified
Saposhnikovia divaricataSaposhnikovia divaricata[14.1 mg,450 mg]Not identified
Mentha haplocalyxMentha haplocalyx[12.5 mg,450 mg]Not identified
Arctium lappaArctium lappa[12.5 mg,450 mg]Not identified
Scrophularia ningpoensisScrophularia ningpoensis[12.5 mg,450 mg]Not identified
Isatis indigoticaIsatis indigotica[12.5 mg,450 mg]Not identified
Elephantopus scaberElephantopus scaber[12.5 mg,450 mg]Not identified
Scutellaria baicalensisScutellaria baicalensis[12.5 mg,450 mg]Not identified
Bupleurum chinenseBupleurum chinense[12.5 mg,450 mg]Not identified
Taraxacum mongolicumTaraxacum mongolicum[12.5 mg,450 mg]Not identified
Vitex trifoliaVitex trifolia[9.4 mg,450 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL26076060TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
WAISENCE SDN BHD
Manufacturer
WAN YEEN TRADING SDN. BHD.
Registration period starting
2026-07-07
Published validity end
2031-07-07

Original register data

View published fields and their variants
Active ingredients
Lonicera japonica[37.5 mg,450 mg],Forsythia suspensa[37.5 mg,450 mg],Platycodon grandiflorum[28.2 mg,450 mg],Inula japonica[28.2 mg,450 mg],Achyranthes bidentata[28.2 mg,450 mg],Rheum palmatum[25 mg,450 mg],Chrysanthemum indicum[25 mg,450 mg],Angelica dahurica[23.4 mg,450 mg],Schizonepeta tenuifolia[18.7 mg,450 mg],Ligusticum chuanxiong[18.7 mg,450 mg],Gardenia jasminoides[18.7 mg,450 mg],Glycyrrhiza uralensis[18.7 mg,450 mg],Gypsum fibrosum[18.7 mg,450 mg],Saposhnikovia divaricata[14.1 mg,450 mg],Mentha haplocalyx[12.5 mg,450 mg],Arctium lappa[12.5 mg,450 mg],Scrophularia ningpoensis[12.5 mg,450 mg],Isatis indigotica[12.5 mg,450 mg],Elephantopus scaber[12.5 mg,450 mg],Scutellaria baicalensis[12.5 mg,450 mg],Bupleurum chinense[12.5 mg,450 mg],Taraxacum mongolicum[12.5 mg,450 mg],Vitex trifolia[9.4 mg,450 mg]
Valid until
2031-07-07
Registration date
2026-07-07
Published description
NATURAL PRODUCT
Licence holder
WAISENCE SDN BHD
Producer
WAN YEEN TRADING SDN. BHD.
Published name
Waisence Q23 Qing Re Capsule
Published reference
2026030521634T
Registration number
MAL26076060TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL26076060TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

  • Arctium lappa
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Waisence Q23 Qing Re Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL26076060TC-waisence-q23-qing-re-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line